Trials / Completed
CompletedNCT05110430
Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans
In Silico Clinical Trial Comparing the Reading Accuracy of Doctors and a Deep Learning Algorithm for Detection of Metastatic Bone Disease on Bone Scintigraphy Scans.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,365 (actual)
- Sponsor
- Maastricht University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Bone scintigraphy scans are two dimensional medical images that are used heavily in nuclear medicine. The scans detect changes in bone metabolism with high sensitivity, yet it lacks the specificity to underlying causes. Therefore, further imaging would be required to confirm the underlying cause. The aim of this study is to investigate whether deep learning can improve clinical decision based on bone scintigraphy scans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Deep learning based detection of metastatic bone disease on bone scintigraphy scans. | The aim is to investigate whether deep learning algorithms can detect bone metastasis with high accuracy and specificity. |
Timeline
- Start date
- 2021-03-10
- Primary completion
- 2021-12-30
- Completion
- 2021-12-31
- First posted
- 2021-11-08
- Last updated
- 2023-03-20
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05110430. Inclusion in this directory is not an endorsement.